MnSOD Levels in Brain Tumors
Author Information
Author(s): M Landriscina, F Remiddi, F Ria, B Palazzotti, ME De Leo, M Iacoangeli, R Rosselli, M Scerrati, T Galeotti
Primary Institution: Catholic University, Rome, Italy
Hypothesis
Can variations of MnSOD be observed in tumors of glial origin with respect to normal controls, and are these variations linked to the degree of differentiation?
Conclusion
The study found that MnSOD levels increase with tumor grade, suggesting it is not a classical tumor-suppressor gene.
Supporting Evidence
- Immunoreactive MnSOD increases in a direct relationship with tumor grade.
- Approximately 30% of grade IV tumors display low levels of MnSOD content.
- Preoperative radiotherapy and brachytherapy result in low amounts of enzyme.
Takeaway
The more serious the brain tumor, the more of a certain protein called MnSOD it has, which is the opposite of what we expected.
Methodology
The study analyzed 33 brain tumors of neuroepithelial origin using Western blot and immunohistology to assess MnSOD levels.
Limitations
The study did not directly address the accelerated progression of low-grade tumors due to limited cases and observation period.
Participant Demographics
21 male and 12 female patients with a mean age of 49.4 years.
Statistical Information
P-Value
0.005
Statistical Significance
p=0.005
Want to read the original?
Access the complete publication on the publisher's website